6. May 2025 | News, Publication
We are thrilled to announce that Stephan Kerkojus has joined our team as our new Business Director. With a wealth of experience and a track record of driving business growth, Stephan Kerkojus is set to play a pivotal role in shaping our company’s future. A Strong...
5. May 2025 | News, Publication
The TAPAS study (“Tyrosine Allergoid Paediatric and Adult Study”) is a large, prospective, multicenter, long-term cohort study designed to evaluate the safety, tolerability, and efficacy of subcutaneous allergen immunotherapy (SCIT) with microcrystalline tespecially...You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information